About this trial

The goal of this clinical trial is to improve the surgical treatment of patients with oral cancer. We will explore whether the use of surgeon performed ultrasound during these surgeries result in better tumor removal. We hypothesize that using intraoperative ultrasound to assist the resection results in more frequent clear surgical margins in oral cancer surgeries compared to standard methods. This improvement is associated with a reduced need for post-operative adjuvant therapies such as radiotherapy and reoperation, lower mortality rates, lower cancer recurrence, and enhanced quality of life for patients undergoing surgery for oral cancer.

Participants will be randomized to either the control or intervention group:

* Control group will receive standard treatment for oral cancer. * Intervention group will in addition to the standard treatment have surgery performed using ultrasound to guide the resection and evaluate resection margins intraoperatively.

Outcomes:

* Number of free surgical margins between control and intervention group. * Intraoperative surgeon assessed surgical margins compared to final histology report. * Dysphagia and quality of life questionnaires. * Recurrence rates. * Mortality rates.

All participant will be followed-up at 3 months and 12 months with:

* MDADI dysphagia questionnaire * EORTC head and neck cancer quality of life questionnaire * Follow-up on recurrrence and mortality.

Eligibility criteria

Qualifiers

None

Disqualifiers

Age < 18 years.

Oral cancer with suspected bone involvement.

Unable to understand verbal or written information.

Prior radiotherapy treatment of oral cavity cancer.

Trial design

Treatments tested in this trial

  • Ultrasound imaging
  • Standard Treatment

Treatment groups

150 Participants
are divided into 2 treatment groups

Locations

7
Denmark
Department of Otorhinolaryngology Head and Neck Surgery8200, Aarhus Denmark
Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet Copenhagen Denmark
Italy
Istituto Nazionale Tumori of Milan20133, Milan Italy
South Africa
Groote Schuur7935, Cape Town South Africa

Sponsors and collaborators

Tobias Todsen

Lead sponsor

Rigshospitalet, Denmark

Sponsor institution

Karolinska Institutet

Collaborator

National Cancer Institute, Milan

Collaborator

Aarhus University Hospital

Collaborator

Odense University Hospital

Collaborator

Aalborg University Hospital

Collaborator